Answers are grounded in this paper and cite their sources.
Gadolinium (Gd)‐based nanoparticles are known for their high potential in magnetic resonance imaging (MRI). However, further MRI applications of these nanoparticles are hampered by their relatively large sizes resulting in poor organ/tumor targeting. In this study, ultrafine sub‐10 nm and biocompatible Gd‐based nanoparticles are synthesized in a bioinspired, environmentally benign, and straightforward fashion. This novel green synthetic strategy is developed for growing dextran‐coated Gd‐based nanoparticles (GdNPs@Dex). The as‐prepared GdNPs@Dex is not only biocompatible but also stable with a sub‐10 nm size. It exhibits higher longitudinal and transverse relaxivities in water ( r 1 and r 2 values of 5.43 and 7.502 s −1 × 10 −3 m −1 of Gd 3+ , respectively) than those measured for Gd–DTPA solution ( r 1 and r 2 values of 3.42 and 3.86 s −1 × 10 −3 m −1 of Gd 3+ , respectively). In vivo dynamic T 1 ‐weighted MRI in tumor‐bearing mice shows GdNPs@Dex can selectively target kidneys and tumor, in addition to liver and spleen. GdNPs@Dex is found particularly capable for determining the tumor boundary with clearly enhanced tumor angiogenesis. GdNPs@Dex is also found cleared from body gradually mainly via hepatobiliary and renal processing with no obvious systemic toxicity. With this green synthesis strategy, the sub‐10 nm GdNPs@Dex presents promising potentials for translational biomedical imaging applications.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: